Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JP9Y | ISIN: DK0060336014 | Ticker-Symbol: NZM2
Tradegate
28.03.24
11:29 Uhr
54,96 Euro
+0,24
+0,44 %
1-Jahres-Chart
NOVONESIS A/S Chart 1 Jahr
5-Tage-Chart
NOVONESIS A/S 5-Tage-Chart
RealtimeGeldBriefZeit
54,5455,0211:36
54,5454,9611:36

Aktuelle News zur NOVONESIS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiNASDAQ OMX Nordic: Change of name and ticker code for Novozymes (97/24)162The Extraordinary General Meeting (EGM) of Novozymes A/S (Novozymes) held on March 4, 2024 approved a secondary name of the company Novonesis A/S. As a consequence of the name change, Novozymes has...
► Artikel lesen
FrNovonesis showcased mood support probiotic at Expo West: MindAble 1714 targets gut-brain axis11
21.03.Novozymes A/S: 2024 outlook and pro forma financials47
18.03.Novozymes A/S: Novonesis will host a conference call regarding 2024 outlook and 2023 pro forma financials on March 2115
18.03.Biotalys NV: Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG369Press release - inside information Biotalys and Novonesis have entered into an agreement to advance EVOCA NG - the next generation of Biotalys' product candidate EVOCA* - to the final stage of development.Pending...
► Artikel lesen
12.03.FMC Canada to distribute Novonesis biosolutions in 202519
08.03.NASDAQ OMX Nordic: Anticipated change of name and ticker code for Novozymes (67/24)354The Extraordinary General Meeting (EGM) of Novozymes A/S (Novozymes) held on March 4, 2024, approved a secondary name of the company Novonesis A/S. As a consequence, Novozymes has changed its stock...
► Artikel lesen
05.03.Nasdaq Copenhagen A/S: Novozymes A/S - change of share name to Novonesis (Novozymes)B292The changes below will take effect on Nasdaq Copenhagen as per 6 March 2024. ISIN: DK0060336014 ------------------------------------------------ Name Novozymes B ...
► Artikel lesen
04.03.Novozymes A/S: Resolutions from the Extraordinary Shareholders' Meeting 2024241Company Announcement no. 10 March 4, 2024Today an extraordinary shareholders' meeting was conducted. The following resolutions were made: Adoption of Novonesis A/S as secondary name and amendment...
► Artikel lesen
09.02.Invitation to an extraordinary shareholders' meeting of Novozymes A/S29
02.02.Novonesis emerges from Chr. Hansen-Novozymes merger: The new company offers enzymes, microbial technologies and ingredients43
02.02.Novozymes A/S: Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed366Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed February 2, 2024Company announcement No. 07 On January 29, 2024, following the satisfaction of all...
► Artikel lesen
01.02.Recap: Novozymes Q4 Earnings31
01.02.Novozymes A/S: Legacy Novozymes delivers solid last full-year results446Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023. This marks the...
► Artikel lesen
31.01.Novozymes A/S: Total number of voting rights and capital on January 31, 20247
29.01.Novozymes A/S: Trading by management and close relations of management8
29.01.NASDAQ OMX Nordic: Derivatives: No adjustment in Chr. Hansen Holding due to merger with Novozymes (20/24)322The Boards of Directors of Chr. Hansen Holding A/S (Chr. Hansen Holding) and Novozymes A/S (Novozymes) have announced today about the completion of the combination of the two companies through a merger...
► Artikel lesen
29.01.Jefferies sees above peer growth for Novozymes, ups to 'buy'20
29.01.Novozymes A/S: Major shareholder announcement11
29.01.Nasdaq Copenhagen A/S: Novozymes A/S and Chr. Hansen A/S - exchange notice regarding merger433On 30 March 2023 the proposal for merging Novozymes A/S and Chr. Hansen A/S was approved at general meetings held in the two companies. Novozymes A/S is the continuing company. Hence, the following...
► Artikel lesen
Seite:  Weiter >>
52 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1